Why diverse clinical trials matter: the pharmaphorum podcast
In this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business to discuss diversity and equity in clinical trials.
They discuss the nitty-gritty of clinical trial diversity – why it’s been so hard to achieve, why it’s important, and how to overcome the specific barriers to inclusion for different underrepresented communities. Jennifer discusses how Abbott has approached these issues in the clinical trials for their vascular medical devices.
Tune in for a frank, detailed, and solution-oriented conversation about one of the most important topics in clinical trials today, and learn how the industry can move forward into a more representative future for clinical trials.
You can listen to episode 53 of the pharmaphorum podcast in the player below, download the episode to your computer or find it – and subscribe to the rest of the series in iTunes, Spotify, acast, Stitcher and Podbean.
